• iSono Health is revolutionizing breast health monitoring with an AI-driven platform, making regular screening and early detection of breast cancer more accessible and personalized for women globally.
  • The platform uses advanced ultrasound technology combined with AI to provide accurate and real-time imaging, allowing for early detection and intervention, which is critical in improving patient outcomes.
  • iSono Health aims to democratize access to breast health monitoring through a portable and user-friendly device, enabling continuous and regular breast health assessments outside of traditional clinical settings.

Breast cancer continues to be one of the most prevalent cancers affecting women worldwide, with almost 30% of new cancer cases, every year, in the U.S. alone, and one of the leading causes of death followed very closely by lung cancer.

This emphasizes the importance of early detection and regular monitoring to help reduce the mortality rates associated with breast cancer.

However, traditional breast cancer screening methods like mammography can be very limiting in terms of accessibility, frequency, and comfort.

iSono Health rises against this backdrop, by transforming breast health monitoring through its ground-breaking platform, powered by artificial intelligence.

A Paradigm Shift in Breast Health Programs

iSono Health is revolutionizing the healthcare industry through its pioneering medical device, ATUSA, to provide highly accurate and real-time imaging of breast tissue.

ATUSA is the world's first AI-driven portable and automated 3D breast ultrasound scanner.

ATUSA scanner automatically captures the entire breast volume allowing for repeatable breast ultrasound operation.

With its proprietary scan method, advanced 3D visualizations are available at the fingertips. This helps diagnose and monitor patients more efficiently.

Major Features of ATUSA include the following:

Automated 3D Ultrasound Scans

With comprehensive 3D scanning and lesion localization, ATUSA provides the best ultrasound imaging without needing a trained ultrasound operator.

It also features reproducible whole breast image acquisition and analysis performed consistently across patients.

Unmatched Speed of Scanning

ATUSA's wearable accessory and intuitive user interface ensure fast image acquisition. With scans ready in 2 minutes, ATUSA is 10-15 times faster than manual probing.

Operator-Agnostic

Expert results are available at the point of care without requiring a trained ultrasound operator offering a fully automated and hands-free scanning experience.

The Transformative Power of AI in Healthcare

The healthcare industry has long seen advanced innovative measures that offer effective solutions in the diagnosis and prognosis of a disease.

With the advent of AI in the industry, the process of diagnosis has never been better.

Founded by Maryam Ziaei and Shadi Saberi, in 2015, this US-based medi-tech company is a game-changer in the field of breast health monitoring.

"Breast cancer is the leading cause of cancer death among women worldwide, and one in eight women will be diagnosed with breast cancer in their lifetime. We founded iSono Health with the vision to enable earlier diagnosis and treatment for breast cancer to save women’s lives, and this FDA clearance is a major step to fulfilling that vision,” said Maryam Ziaei, Ph.D., Co-Founder and CEO of iSono Health.

iSono Health is supported by a National Science Foundation SBIR grant, Y Combinator, Foothill Ventures, Texas Medical Center Innovation, and other top medical centers and investors.

The company has also successfully raised approximately $8 million in funding across various rounds, with support from prominent investors including Y Combinator and other venture capital firms.

This funding is being utilized to further develop the technology, expand market reach, and enhance the AI algorithms, aiming to make regular breast health monitoring a global standard.

As the company continues to innovate and grow, its impact on women's health globally is expected to be profound.

Edited By Annette George